Health
South African variant can ‘break through’ Pfizer vaccine, Israeli study says – Reuters
The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found,…
By Maayan Lubell
JERUSALEM (Reuters) – The coronavirus variant discovered in South Africa can break through Pfizer/BioNTechs COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients…
-
Noosa News22 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News21 hours agoFranz Ferdinand: Australian Tour 2025
-
General21 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General14 hours agoDavid Littleproud’s own goal • Inside Story